Bio-IT World | A review of coronavirus immunity studies suggest the COVID-19 virus could become the fifth seasonal coronavirus with recurring epidemics of lessening severity over the next several years. Over 200 SARS-CoV-2 genome sequences have now been completed and released. We round up the week’s research and industry news for COVID-19.

• The Elucid Digital Health screw on dispenser cap + app prompts compliance, messages patients, records temperature and humidity and provides real time reports for doctors or monitors

• Compliance in clinical trials is a serious problem with patients failing to comply - deteriorating as the trial progresses

• Non-compliance is estimated by the OECD to cause 200,000 premature deaths in Europe and estimated to cost E 125 billion in EU $105 billion in the US annually in avoidable hospitalisations, emergency care, and outpatient visitsx

Bio-IT World | The University of Pennsylvania and Intel have built a federation of 30 institutions to use federated learning to train artificial intelligence models to identify boundaries of brain tumors.

Bio-IT World May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Benchling, BERG, Thermo Fisher Scientific, and more.

Bio-IT World Contributed Commentary | Few disciplines have seen more rapid adoption of cloud computing than life sciences research. Datasets are easily anonymized; pipelines are generally comprised of cloud-friendly open-source tools, and data are often shared, making the cloud a convenient meeting point. Overshadowing all of these reasons, however, is an insatiable demand for computing power.

Bio-IT World | A pair of studies demonstrate antibody responses to COVID-19 in primates. Researchers are applying artificial intelligence to lung images of COVID-19 patients. An accurate, easy-to-use, fully disposable, rapid and handheld test that consumers and healthcare providers in clinics can use to detect active SARS-CoV-2. We round up the week’s research and industry news for COVID-19.